B-cell depleters attenuate the humoral response to SARS-CoV-2 vaccines in multiple sclerosis patients: A case-control study
Author:
Funder
Novartis
Publisher
Elsevier BV
Subject
Neurology (clinical),Neurology,General Medicine
Reference16 articles.
1. Achiron, A., Mandel, M., Dreyer-Alster, S., Harari, G., Magalashvili, D., Sonis, P., Dolev, M., Menascu, S., Flechter, S., Falb, R., Gurevich, M., 2021. Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies: 10.1177/17562864211012835 14. 10.1177/17562864211012835.
2. Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: the VELOCE study;Bar-Or;Neurology,2020
3. Impact of disease-modifying treatments on humoral response after COVID-19 vaccination: a mirror of the response after SARS-CoV-2 infection;Bigaut;Rev. Neurol.,2021
4. Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial;Bingham;Arthritis Rheum.,2010
5. Attenuation of antibody response to SARS-CoV-2 infection in patients with multiple sclerosis on ocrelizumab: a case-control study;Conte;Mult. Scler. Relat. Disord.,2021
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Longevity of the humoral and cellular responses after SARS-CoV-2 booster vaccinations in immunocompromised patients;European Journal of Clinical Microbiology & Infectious Diseases;2023-11-13
2. Humoral immune response to COVID-19 mRNA vaccines in patients with relapsing multiple sclerosis treated with ofatumumab;Multiple Sclerosis and Related Disorders;2023-11
3. Immune Response to Initial and Booster SARS-CoV-2 mRNA Vaccination in Patients Treated with Siponimod—Final Analysis of a Nonrandomized Controlled Clinical Trial (AMA-VACC);Vaccines;2023-08-16
4. Longitudinal COVID-19 immune trajectories in patients with neurological autoimmunity on anti-CD20 therapy;Multiple Sclerosis and Related Disorders;2022-12
5. Clinical and immunological features associated to the development of a sustained immune humoral response in COVID-19 patients: Results from a cohort study;Frontiers in Immunology;2022-08-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3